| Dr Todd W Stull, MD | |
|
12365 Huron St Ste 1600, Westminster, CO 80234-3496 | |
| (970) 528-5030 | |
| Not Available |
| Full Name | Dr Todd W Stull |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 32 Years |
| Location | 12365 Huron St Ste 1600, Westminster, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043289069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 19176 (Nebraska) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | DR.0065259 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Methodist Fremont Health | 7911258520 | 67 |
News Archive
Scientists from University of North Carolina at Chapel Hill School of Medicine and Interleukin Genetics, Inc. announced today findings from a large clinical study to evaluate the role played by genetic factors in the worsening of osteoarthritis.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.
For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, will be presenting data from the NeuVax Phase II adjuvant breast cancer clinical trial at the 2011 annual meeting of The American Society of Clinical Oncology in Chicago.
› Verified 9 days ago
| Entity Name | Methodist Fremont Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235618216 PECOS PAC ID: 7911258520 Enrollment ID: O20181017000110 |
News Archive
Scientists from University of North Carolina at Chapel Hill School of Medicine and Interleukin Genetics, Inc. announced today findings from a large clinical study to evaluate the role played by genetic factors in the worsening of osteoarthritis.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.
For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, will be presenting data from the NeuVax Phase II adjuvant breast cancer clinical trial at the 2011 annual meeting of The American Society of Clinical Oncology in Chicago.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd W Stull, MD 1650 S Topaz Way, Meridian, ID 83642-4474 Ph: (208) 605-7070 | Dr Todd W Stull, MD 12365 Huron St Ste 1600, Westminster, CO 80234-3496 Ph: (970) 528-5030 |
News Archive
Scientists from University of North Carolina at Chapel Hill School of Medicine and Interleukin Genetics, Inc. announced today findings from a large clinical study to evaluate the role played by genetic factors in the worsening of osteoarthritis.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.
For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, will be presenting data from the NeuVax Phase II adjuvant breast cancer clinical trial at the 2011 annual meeting of The American Society of Clinical Oncology in Chicago.
› Verified 9 days ago
Dr. Nancy Karrel Griffin Stebbins, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7701 Sheridan Blvd, Westminster, CO 80003 Phone: 303-338-4545 | |
Dr. Gregory F Kellermeyer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7701 Sheridan Blvd, Westminster, CO 80003 Phone: 303-338-4545 | |
Ernest Edward Nitka, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 303-952-4060 Fax: 303-925-4061 | |
Dr. Glenn Tetsuo Kimata, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8771 Wolff Ct, Suite 115, Westminster, CO 80031 Phone: 303-650-8005 Fax: 303-412-5891 | |
Dr. Andreea I Arvinte, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7701 Sheridan Blvd, Westminster, CO 80003 Phone: 303-338-4545 | |
Kimberly A Horiuchi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 303-925-4060 Fax: 303-925-4061 |